Product Information
TRIHEXYPHENIDYL 2 MG/5 ML SOLN is a generic product labeled by PAI Holdings LLC, priced at $0.1586 per ML under NDC 00121065816. Its NADAC has been published 473 times since Nov 28, 2013.
FDA first approved this application on Apr 17, 1997. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Trihexyphenidyl Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/5mL
Manufacturer
PAI Holdings LLCNDC
00121065816
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TRIHEXYPHENIDYL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040177FDA Approved
4/17/1997
TE Code
AA
On Market Since
5/15/1997
Price Statistics
The NADAC for TRIHEXYPHENIDYL 2 MG/5 ML SOLN has been published 473 times since Nov 28, 2013, and over the history we have for it it has risen 324.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1586 per ML |
|---|---|
| All-time high | $0.1586 (Sep 23, 2026) |
| All-time low | $0.0308 (Sep 17, 2014) |
| 52-week high | $0.1586 |
| 52-week low | $0.0663 |
| Median price | $0.0619 |
| Average price | $0.0560 |
| Largest weekly change | +62.3% (Sep 23, 2026) |
| Weeks tracked | 473 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Trihexyphenidyl Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PAI Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Trihexyphenidyl Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIHEXYPHENIDYL 2 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for TRIHEXYPHENIDYL 2 MG/5 ML SOLN, manufactured by PAI Holdings LLC, is $0.1586 per ML (NDC 00121065816), effective Sep 23, 2026.
How has the price of TRIHEXYPHENIDYL 2 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for TRIHEXYPHENIDYL 2 MG/5 ML SOLN has risen 324.9%. It has been tracked across 473 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRIHEXYPHENIDYL 2 MG/5 ML SOLN?
Since Nov 28, 2013, the NADAC for TRIHEXYPHENIDYL 2 MG/5 ML SOLN has ranged from a low of $0.0308 (Sep 17, 2014) to a high of $0.1586 (Sep 23, 2026), with a median of $0.0619 per ML.
Are there cheaper alternatives to TRIHEXYPHENIDYL 2 MG/5 ML SOLN?
No other NADAC-published product currently shares the active ingredient and strength of TRIHEXYPHENIDYL 2 MG/5 ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRIHEXYPHENIDYL 2 MG/5 ML SOLN?
TRIHEXYPHENIDYL 2 MG/5 ML SOLN (NDC 00121065816) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.